182 related articles for article (PubMed ID: 28135023)
1. Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder.
Köhler-Forsberg O; Sylvia L; Thase M; Calabrese JR; Deckersbach T; Tohen M; Bowden CL; McInnis M; Kocsis JH; Friedman ES; Ketter TA; McElroy S; Shelton RC; Nierenberg AA
Depress Anxiety; 2017 Mar; 34(3):281-290. PubMed ID: 28135023
[TBL] [Abstract][Full Text] [Related]
2. Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.
Bobo WV; Reilly-Harrington NA; Ketter TA; Brody BD; Kinrys G; Kemp DE; Shelton RC; McElroy SL; Sylvia LG; Kocsis JH; McInnis MG; Friedman ES; Singh V; Tohen M; Bowden CL; Deckersbach T; Calabrese JR; Thase ME; Nierenberg AA; Rabideau DJ; Schoenfeld DA; Faraone SV; Kamali M
J Affect Disord; 2014 Jun; 161():30-5. PubMed ID: 24751304
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes of acute bipolar depressive episode with psychosis.
Caldieraro MA; Dufour S; Sylvia LG; Gao K; Ketter TA; Bobo WV; Walsh S; Janos J; Tohen M; Reilly-Harrington NA; McElroy SL; Shelton RC; Bowden CL; Deckersbach T; Nierenberg AA
Depress Anxiety; 2018 May; 35(5):402-410. PubMed ID: 29329498
[TBL] [Abstract][Full Text] [Related]
4. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
[TBL] [Abstract][Full Text] [Related]
5. Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder.
Nierenberg AA; McElroy SL; Friedman ES; Ketter TA; Shelton RC; Deckersbach T; McInnis MG; Bowden CL; Tohen M; Kocsis JH; Calabrese JR; Kinrys G; Bobo WV; Singh V; Kamali M; Kemp D; Brody B; Reilly-Harrington NA; Sylvia LG; Shesler LW; Bernstein EE; Schoenfeld D; Rabideau DJ; Leon AC; Faraone S; Thase ME
J Clin Psychiatry; 2016 Jan; 77(1):90-9. PubMed ID: 26845264
[TBL] [Abstract][Full Text] [Related]
6. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
Kim SJ; Lee YJ; Lee YJ; Cho SJ
J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
[TBL] [Abstract][Full Text] [Related]
7. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice.
Shajahan P; Taylor M
J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493
[TBL] [Abstract][Full Text] [Related]
8. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
Amsterdam JD; Wang CH; Shwarz M; Shults J
J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
10. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
11. Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium.
Ketter TA; Miller S; Dell'Osso B; Wang PW
J Affect Disord; 2016 Feb; 191():256-73. PubMed ID: 26688495
[TBL] [Abstract][Full Text] [Related]
12. Acetaminophen, Nonsteroidal Anti-inflammatory Drugs, or Combination of Both Analgesics in Acute Posttrauma Pain: A Randomized Controlled Trial.
Msolli MA; Sekma A; Toumia M; Bel Haj Ali K; Khalil MH; Grissa MH; Bouida W; Beltaief K; Zorgati A; Methamem M; Belguith A; Boukef R; Boubaker H; Nouira S
Acad Emerg Med; 2021 Feb; 28(2):155-163. PubMed ID: 33145862
[TBL] [Abstract][Full Text] [Related]
13. Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale.
Kinrys G; Bowden CL; Nierenberg AA; Hearing CM; Gold AK; Rabideau DJ; Sylvia LG; Gao K; Kamali M; Bobo WV; Tohen M; Deckersbach T; McElroy SL; Ketter TA; Shelton RC; Friedman ES; Calabrese JR; McInnis MG; Kocsis J; Thase ME; Singh V; Reilly-Harrington NA
J Affect Disord; 2019 Mar; 246():126-131. PubMed ID: 30580198
[TBL] [Abstract][Full Text] [Related]
14. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain.
Ong CK; Seymour RA; Lirk P; Merry AF
Anesth Analg; 2010 Apr; 110(4):1170-9. PubMed ID: 20142348
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.
Nierenberg AA; Sylvia LG; Leon AC; Reilly-Harrington NA; Shesler LW; McElroy SL; Friedman ES; Thase ME; Shelton RC; Bowden CL; Tohen M; Singh V; Deckersbach T; Ketter TA; Kocsis JH; McInnis MG; Schoenfeld D; Bobo WV; Calabrese JR;
Clin Trials; 2014 Feb; 11(1):114-27. PubMed ID: 24346608
[TBL] [Abstract][Full Text] [Related]
16. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side effects after major surgery: a systematic review.
McDaid C; Maund E; Rice S; Wright K; Jenkins B; Woolacott N
Health Technol Assess; 2010 Mar; 14(17):1-153, iii-iv. PubMed ID: 20346263
[TBL] [Abstract][Full Text] [Related]
17. Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
Nierenberg AA; Friedman ES; Bowden CL; Sylvia LG; Thase ME; Ketter T; Ostacher MJ; Leon AC; Reilly-Harrington N; Iosifescu DV; Pencina M; Severe JB; Calabrese JR
Am J Psychiatry; 2013 Jan; 170(1):102-10. PubMed ID: 23288387
[TBL] [Abstract][Full Text] [Related]
18. Add-on quetiapine for bipolar depression: a 12-month open-label trial.
Milev R; Abraham G; Zaheer J
Can J Psychiatry; 2006 Jul; 51(8):523-30. PubMed ID: 16933589
[TBL] [Abstract][Full Text] [Related]
19. Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial.
Sylvia LG; Chang WC; Kamali M; Tohen M; Kinrys G; Deckersbach T; Calabrese JR; Thase ME; Reilly-Harrington N; Bobo WV; Kocsis JH; McInnis MG; Bowden CL; Ketter TA; Friedman ES; Shelton RC; McElroy SL; Gao K; Rabideau DJ; Nierenberg AA
J Affect Disord; 2018 Jan; 225():563-568. PubMed ID: 28881294
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis.
Fajutrao L; Paulsson B; Liu S; Locklear J
Clin Ther; 2009 Jun; 31 Pt 1():1456-68. PubMed ID: 19698903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
